查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1606471

生物技術成分市場，按類型、表達系統、應用和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Biotech Ingredients Market, By Type, By Expression System, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

生技成分市場預計到 2023 年將達到 21.515 億美元，並在 2024 年至 2032 年間以 8.00% 的複合年成長率擴張。

生物技術成分市場-市場動態

對非專利藥物的需求不斷成長

由於對學名藥的需求不斷成長，預計生物技術成分市場將繼續擴大。學名藥旨在與先前授權的藥物具有相同的品質。普通醫學使用生物技術物質，因為它們是生產各種活性成分的更便宜、更有效的方法的主要來源，這些活性成分幾乎與原始產品相當，並且通常受到更嚴格的法規的約束。例如，2022 年 9 月，美國學名藥製造商和分銷商協會無障礙藥物協會 (AAM) 下屬生物相似藥委員會發布的《美國學名藥和生物學名藥節省報告》顯示，91% 2021 年，美國有64 億張處方是為患者開立的學名藥或生物相似藥。由於學名藥佔所有醫療保健支出的 3%，患者、消費者、雇主和納稅人透過使用這些較便宜的藥物節省了 3,730 億美元。因此，由於對學名藥的需求增加，生物技術成分的市場正在擴大。

生物技術成分市場 - 關鍵見解

根據我們的研究分析師的分析，在 2024 年至 2032 年的預測期內，全球市場預計將以約 8.00% 的複合年成長率擴張。

根據類型，預計活性藥物成分類別將在 2023 年佔據最大的市場佔有率。

根據表達系統，預計微生物表達系統類別將在 2023 年佔據最大的市場佔有率。

2023 年，按地區分類，北美地區的收入佔有率最大。

生物技術成分市場-細分分析：

全球生物技術成分市場分為類型、表達系統、應用和區域。

全球生物技術成分市場根據類型分為兩個部分：生物相似藥和活性藥物成分。 2023年，市場最大貢獻者是活性藥物成分類別。活性藥物成分 (API) 是最終產品或成品中使用的化學物質或物質混合物。它們旨在用於藥理學研究，以研究藥物在用於治療不同疾病時對生物體的影響。當研究與不同診斷、治療、預防、治療和緩解目標直接相關的原因和後果時，會使用 API。在大多數情況下，配方使用熱力學最穩定的 API 晶型。 API 的品質強烈影響藥品的功效和安全性。

根據應用，市場分為疫苗、單株抗體、細胞激素、荷爾蒙和生長因子、融合蛋白、血液因子和治療酵素。由於其高特異性、低毒性以及針對特定疾病標記的能力，單株抗體預計將主導全球生物技術成分市場。此外，慢性病發病率的增加和對個人化治療選擇的需求將推動市場擴張。稱為單株抗體 (mAb) 的合成蛋白質可複製免疫系統透過針對特定細胞或蛋白質來擊退入侵者的能力。這些生物技術成分因其在治療許多疾病（包括癌症、自體免疫疾病和傳染病）方面的治療應用而在製藥業顯著成長。

生技成分市場 - 地理洞察

生物技術成分市場廣泛分佈在北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據提供業務的國家進一步分類。

生物技術成分市場由北美主導，主要是因為該地區擁有強大的製藥和食品公司以及對生物技術研發的大量投資。該地區成熟的醫療保健系統和有利的監管環境有助於市場的擴張。由於食品和飲料、化妝品和藥品中對生物技術成分的需求不斷成長，美國是該市場的重要貢獻者。在不斷成長的生物技術投資和消費者對永續產品意識不斷增強的幫助下，加拿大也正在經歷快速成長。

此外，在大量製藥和化妝品公司的幫助下，以及消費者對永續產品不斷成長的需求，歐洲也佔據了生物技術成分市場的相當大一部分。該市場主要由德國、法國和英國推動，這些國家都在生物技術研發方面投入了大量資金。該地區嚴格的法規和對環境永續性的重視推動了生物技術物質的使用。此外，天然和有機產品的日益普及正在推動歐洲生物技術成分市場的擴張。

生物技術成分市場-競爭格局：

生物技術成分市場的特點是競爭環境充滿活力，隨著各行業對尖端生物技術解決方案的需求不斷擴大，許多老牌公司和新來者都在爭奪市場佔有率。艾伯維公司、輝瑞公司、勃林格殷格翰國際有限公司、禮來公司、葛蘭素史克公司、諾華公司等重要公司始終致力於研發專案以擴大其產品線，強調技術改進、永續商業實踐和監管合規。為了滿足不斷變化的客戶需求並保持市場競爭優勢，產業參與者正試圖透過策略聯盟、併購擴大其全球影響力並提供各種生物技術成分。

最新進展：

2023 年 5 月：著名生物技術公司 Willow Biosciences Inc. 旨在徹底改變永續和純功能成分的工業生產，與一家專注於與年齡相關疾病的尖端生物技術公司簽署了主服務協議。在此次合作中，它將為特定類別的分子開發精確的發酵工藝，這些分子可作為活性藥物成分 (API) 和保健營養補充劑。

2023 年 2 月：CETO3 是 Grntvedt Biotech 推出的一種 omega-3 和鯨油酸。已研究鯨油酸（有時稱為“omega 11”）是否可以將α-硫辛酸(ALA)（一種植物性omega-3 脂肪酸）轉變為二十碳五烯酸(EPA) 和二十二碳六烯酸(DHA)。它是一種來自挪威鯡魚的化學物質，可用於皮膚和心臟健康。

2022 年 2 月：愛爾蘭口味和營養巨頭 Kerry Group plc 以 2.26 億美元收購了 c-LEcta。凱愛瑞希望透過此次收購加強其在發酵、酵素工程和生物技術開發方面的創新力度。凱愛瑞也打算投資開發創新的永續技術，以推動永續食品和衛生系統的未來發展。 c-LEcta是一家總部位於德國的生物技術創新公司，專門透過極其精確的發酵、最佳化的生物加工和生物轉化來生產高價值的目標生物分子和成分。

目錄

第1章：生物技術成分市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的生物技術成分市場片段
    • 表達系統的生物技術成分市場片段
    • 生物技術成分市場片段（按應用）
    • 按國家/地區分類的生物技術成分市場摘要
    • 按地區分類的生物技術成分市場片段
  • 競爭洞察

第 3 章：生物技術成分主要市場趨勢

  • 生物技術成分市場促進因素
    • 市場促進因素的影響分析
  • 生物技術成分市場限制
    • 市場限制影響分析
  • 生物技術成分市場機會
  • 生物技術成分市場未來趨勢

第 4 章：生物技術成分產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：生物技術成分市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：生技成分市場格局

  • 2023 年生物技術成分市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：生物技術成分市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 生物相似藥
    • 活性藥物成分

第 8 章：生物技術成分市場 - 按表達系統

  • 概述
    • 依表達系統進行細分市場佔有率分析
    • 植物表達系統
    • 哺乳動物表達系統
    • 酵母表現系統
    • 微生物表現系統
    • 昆蟲表達系統

第 9 章：生物技術成分市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 疫苗
    • 單株抗體
    • 細胞因子
    • 荷爾蒙和生長因子
    • 融合蛋白
    • 血液因素
    • 治療酵素

第 10 章：生物技術成分市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生物技術成分主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測（按表達系統）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生物技術成分主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按表達系統）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區生物技術成分主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按表達系統）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物技術成分主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按表達系統）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲生物技術成分主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按表達系統）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 生技成分產業

  • 競爭儀表板
  • 公司簡介
    • AbbVie Inc. (US)
    • Pfizer Inc. (US)
    • Boehringer Ingelheim International GmbH. (Germany)
    • Lilly (US)
    • GSK Plc (UK)
    • Novartis AG (Switzerland)
    • Bristol-Myers Squibb Company (US)
    • Merck & Co (US).
    • Sanofi (France)
    • bioMerieux (France)
    • Cepheid Inc. (US)
    • AstraZeneca (UK)
    • Mylan NV (US)
    • BD (US)
    • Teva Pharmaceutical Industries Ltd. (Israel)
    • Bruker (US)
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4267

REPORT HIGHLIGHT

The market for Biotech Ingredients was projected to reach USD 2,151.5 million in 2023 and expand at a CAGR of 8.00% between 2024 - 2032.

The majority of biotech ingredients are natural and include oleoresins, essential oils, and other plant extracts. Common methods for obtaining these compounds include carbon dioxide extraction, solvent extraction, steam distillation, and cold pressing or compression. Biotech ingredients, like biopharmaceuticals, include complex proteins, such antibodies, nucleic acids, or antisense oligonucleotides, which are given by methods different from direct extraction from natural, non-engineered living forms. Due to reasons including consumers' growing preference for natural and organic products, the market for biotech ingredients has grown significantly. Additionally, this market is being driven by the growing usage of biotech components in various end-use industries, including medicines, cosmetics, and food & beverage. In addition, technological developments pertaining to monoclonal antibodies and next-generation antibody therapeutics, including antibody-drug conjugates by major companies, are some other aspects anticipated to further influence the biotech ingredients market.

Biotech Ingredients Market- Market Dynamics

Rising Need for Generic Medications

It is anticipated that the market for biotech ingredients will continue to expand due to the growing need for generic medications. A generic medication is intended to have the same qualities as a previously authorized medication. General medicine uses biotech substances because they are the main source of less expensive, more effective ways to produce a variety of active ingredients that are almost comparable to the original product and are usually subject to a more stringent set of regulations. For instance, in September 2022, the U.S. Generic and Biosimilar Medicines Savings Report, published by the Biosimilars Council, a division of the Association for Accessible Medicines (AAM), a US-based association of generic medicine manufacturers and distributors, revealed that 91% of the 6.4 billion prescriptions were written for patients in the US in 2021 for generic or biosimilar medications. With generic medications accounting for 3% of all healthcare spending, patients, consumers, employers, and taxpayers saved $373 billion by using these less expensive medications. Thus, the market for biotech ingredients is expanding due to the increased demand for generic medications.

Biotech Ingredients Market- Key Insights

According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 8.00% during the forecast period of 2024-2032.

The active pharmaceutical ingredients category was predicted to hold the largest market share in 2023 based on type.

The microbial expression systems category was predicted to hold the largest market share in 2023 based on expression systems.

North America held the largest revenue share by region in 2023.

Biotech Ingredients Market- Segmentation Analysis:

The Global Biotech Ingredients Market is segmented into Type, Expression System, Application, and Region.

The global market for biotech ingredients is divided into two segments based on type: biosimilars and active pharmaceutical ingredients. In 2023, the market's largest contributor is the active pharmaceutical ingredients category. Active pharmaceutical ingredients (APIs) are the chemicals or a mixture of substances utilized in final or finished products. They are intended for use in pharmacology studies to investigate the effects of drugs on living organisms when they are used to treat different diseases. When researching causes and consequences that are directly related to different diagnoses, cures, preventive, therapy, and mitigation aims, APIs are used. In most cases, a formulation uses the most thermodynamically stable crystalline form of API. The quality of APIs strongly impacts the efficacy and safety of pharmaceuticals.

Based on application, the market is segmented into Vaccines, Monoclonal Antibodies, Cytokines, Hormones and Growth Factors, Fusion Proteins, Blood Factors, and Therapeutic Enzymes. Due to its high specificity, low toxicity, and capacity to target particular disease markers, monoclonal antibodies are expected to dominate the global market for biotech ingredients. Additionally, the growing incidence of chronic illnesses and the demand for individualized treatment options will propel market expansion. Synthetic proteins known as monoclonal antibodies (mAbs) replicate the immune system's ability to fight off intruders by targeting particular cells or proteins. These biotech components have grown significantly in the pharmaceutical industry because of their therapeutic applications in the treatment of many illnesses, including cancer, autoimmune diseases, and infectious diseases.

Biotech Ingredients Market- Geographical Insights

The Biotech Ingredients market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.

The market for biotech ingredients is dominated by North America, mostly because of the region's strong pharmaceutical and food companies as well as its substantial investments in biotechnology R&D. The market's expansion is being aided by the region's established healthcare system and advantageous regulatory environment. Due to the increasing demand for biotech ingredients in food and drink, cosmetics, and pharmaceuticals, the US is a significant contributor to the market. With the help of growing biotechnology investments and growing consumer awareness of sustainable products, Canada is also experiencing rapid growth.

Additionally, with the help of a large number of pharmaceutical and cosmetic firms as well as rising consumer demand for sustainable products, Europe also commands a sizable portion of the market for biotech ingredients. The market is mostly driven by Germany, France, and the United Kingdom, all of which have made large expenditures in biotechnology R&D. The use of biotech substances is being fueled by the region's strict regulations and emphasis on environmental sustainability. Furthermore, the growing popularity of natural & organic products is driving the European biotech ingredients market's expansion.

Biotech Ingredients Market- Competitive Landscape:

The market for biotech ingredients is characterized by a dynamic competitive environment with many well-established companies and newcomers vying for market share in the expanding demand for cutting-edge biotechnology solutions across a range of industries. Important companies such as AbbVie Inc., Pfizer Inc., Boehringer Ingelheim International GmbH, Lilly, GSK Plc, Novartis AG, and others always work on R&D projects to expand their product lines, emphasizing technological improvements, sustainable business practices, and regulatory compliance. In order to meet changing customer demands and maintain a competitive edge in the market, industry players are attempting to broaden their worldwide reach and provide a variety of biotech ingredients through strategic alliances, mergers, and acquisitions.

Recent Developments:

May 2023: The renowned biotech company Willow Biosciences Inc., which aims to revolutionize the industrial production of sustainable and pure functional components, has inked a Master Services Agreement with a cutting-edge biotech company that focuses on age-related illnesses. In this partnership, it will develop precise fermentation processes for a particular class of molecules created as active pharmaceutical ingredients (APIs) and nutritional supplements for health and wellness.

February 2023: CETO3 is an omega-3 and cetoleic acid that Grntvedt Biotech introduced. It has been investigated if cetoleic acid, sometimes referred to as "omega 11," can change alpha-lipoic acid (ALA), a plant-based omega-3 fatty acid, into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in liver cells. It's a chemical from Norwegian herring that's being used for skin and heart health.

February 2022: For $226 million, the Irish taste and nutrition giant Kerry Group plc purchased c-LEcta. Kerry hopes to enhance its innovation efforts in fermentation, enzyme engineering, and biotechnological development with this acquisition. Kerry also intends to make investments in the development of innovative sustainable technologies that will propel the future growth of sustainable food and health systems. c-LEcta is a biotechnology innovation company based in Germany that specializes in producing high-value targeted biomolecules and ingredients through extremely accurate fermentation, optimized bio-processing, and bio-transformation.

SCOPE OF THE REPORT

The scope of this report covers the Biotech Ingredients market by its major segments, which include as follows:

GLOBAL BIOTECH INGREDIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Lilly (U.S.)
  • GSK Plc (U.K.)
  • Novartis AG (Switzerland)
  • Bristol-Myers Squibb Company (U.S.)
  • Merck & Co (U.S.).
  • Sanofi (France)
  • bioMerieux (France)
  • Cepheid Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Mylan N.V (U.S.)
  • BD (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bruker (U.S.)
  • Others

GLOBAL BIOTECH INGREDIENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Biosimilars
  • Active Pharmaceutical Ingredients

GLOBAL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEM- MARKET ANALYSIS, 2019 - 2032

  • Plant Expression Systems
  • Mammalian Expression Systems
  • Yeast Expression Systems
  • Microbial Expression Systems
  • Insect Expression Systems

GLOBAL BIOTECH INGREDIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Vaccines
  • Monoclonal Antibodies
  • Cytokines
  • Hormones and Growth Factors
  • Fusion Proteins
  • Blood Factors
  • Therapeutic Enzymes

GLOBAL BIOTECH INGREDIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biotech Ingredients Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biotech Ingredients Market Snippet by Type
    • 2.1.2. Biotech Ingredients Market Snippet by Expression System
    • 2.1.3. Biotech Ingredients Market Snippet by Application
    • 2.1.4. Biotech Ingredients Market Snippet by Country
    • 2.1.5. Biotech Ingredients Market Snippet by Region
  • 2.2. Competitive Insights

3. Biotech Ingredients Key Market Trends

  • 3.1. Biotech Ingredients Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biotech Ingredients Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biotech Ingredients Market Opportunities
  • 3.4. Biotech Ingredients Market Future Trends

4. Biotech Ingredients Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biotech Ingredients Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biotech Ingredients Market Landscape

  • 6.1. Biotech Ingredients Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biotech Ingredients Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Biosimilars
    • 7.1.3. Active Pharmaceutical Ingredients

8. Biotech Ingredients Market - By Expression System

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Expression System, 2023 & 2032 (%)
    • 8.1.2. Plant Expression Systems
    • 8.1.3. Mammalian Expression Systems
    • 8.1.4. Yeast Expression Systems
    • 8.1.5. Microbial Expression Systems
    • 8.1.6. Insect Expression Systems

9. Biotech Ingredients Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Vaccines
    • 9.1.3. Monoclonal Antibodies
    • 9.1.4. Cytokines
    • 9.1.5. Hormones and Growth Factors
    • 9.1.6. Fusion Proteins
    • 9.1.7. Blood Factors
    • 9.1.8. Therapeutic Enzymes

10. Biotech Ingredients Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biotech Ingredients Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biotech Ingredients Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biotech Ingredients Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Biotech Ingredients Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Biotech Ingredients Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biotech Ingredients Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc. (U.S.)
    • 11.2.2. Pfizer Inc. (U.S.)
    • 11.2.3. Boehringer Ingelheim International GmbH. (Germany)
    • 11.2.4. Lilly (U.S.)
    • 11.2.5. GSK Plc (U.K.)
    • 11.2.6. Novartis AG (Switzerland)
    • 11.2.7. Bristol-Myers Squibb Company (U.S.)
    • 11.2.8. Merck & Co (U.S.).
    • 11.2.9. Sanofi (France)
    • 11.2.10. bioMerieux (France)
    • 11.2.11. Cepheid Inc. (U.S.)
    • 11.2.12. AstraZeneca (U.K.)
    • 11.2.13. Mylan N.V (U.S.)
    • 11.2.14. BD (U.S.)
    • 11.2.15. Teva Pharmaceutical Industries Ltd. (Israel)
    • 11.2.16. Bruker (U.S.)
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us